Friday 11 April 2014

CPT Deleted and New Codes in 2014 for Cardiology


2013 CPT® Description
2014 CPT® Description
0580F -Multidisciplinary care plan developed or updated (ALS)
0581F -Patient transferred directly from anesthetizing location to critical care unit (Peri2)
0582F -Patient not transferred directly from anesthetizing location to critical care unit (Peri2)
0583F -Transfer of care checklist used (Peri2)
0584F -Transfer of care checklist not used (Peri2)
1040F – DSM IV™ criteria for major depressive disorder documented at the initial evaluation (MDD, MDD ADOL)1
•1500F -Symptoms and signs of distal symmetric polyneuropathy, reviewed and documented (DSP)
•1501F -Not initial evaluation for condition (DSP)
•1502F -Patient queried about pain and pain interferences with function using a valid and reliable instrument (DSP)
•1503F -Patient queried about symptoms of respiratory insufficiency (ALS)
•1504F -Patient has respiratory insufficiency (ALS)
•1505F Patient does not have respiratory insufficiency
•3751F – Electrodiagnostic studies for distal symmetric polyneuropathy conducted (or requested), documented, and reviewed within 6 months of initial evaluation for condition (DSP)
•3752F -Electrodiagnostic studies for distal symmetric polyneuropathy not conducted (or requested), documented, or reviewed within 6 months of initial evaluation for condition (DSP)
•3753F -Patient has clear clinical symptoms and signs that are highly suggestive of neuropathy AND cannot be attributed to another condition, AND has an obvious cause for the neuropathy (DSP)
•3754F -Screening tests for diabetes mellitus reviewed, requested, or ordered (DSP)
 •3755F -Cognitive and behavioral impairment screening performed (ALS)
•3756F- Patient has pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
•3757F -Patient does not have pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
•3758F – Patient referred for pulmonary function testing or peak cough expiratory flow (ALS)
•3759F -Patient screened for dysphagia, weight loss, or impaired nutrition (ALS)
•3760F -Patient exhibits dysphagia, weight loss, or impaired nutrition (ALS)
•3761F -Patient does not exhibit dysphagia, weight loss, or impaired nutrition (ALS)
•3762F -Patient is dysarthric (ALS)
•3763F -Patient is not dysarthric (ALS)
•4540F -Disease modifying pharmacotherapy discussed (ALS)
•4541F -Patient offered treatment for pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
•4550F – Options for noninvasive respiratory support discussed with patient (ALS)
•4551F -Nutritional support offered (ALS)
•4552F -Patient offered referral to a speech language pathologist (ALS)”
•4553F -Patient offered assistance in planning for end of life issues (ALS)”
•4554F -Patient received inhalational anesthetic agent (Peri2)”
•4555F -Patient did not receive inhalational anesthetic agent (Peri2)”
•4556F -Patient exhibits 3 or more risk factors for post-operative nausea and vomiting (Peri2)”
•4557F -Patient does not exhibit 3 or more risk factors for post-operative nausea and vomiting (Peri2)”
•4558F -Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and intraoperatively (Peri2)
 •4559F -At least 1 body temperature measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (Peri2)
•4560F -Antesthesia technique did not involve general or neuraxial anesthesia (Peri2)
•4561F -Patient has a coronary artery stent (Peri2)
•4562F – Patient does not have a coronary artery stent (Peri2)
•4563F – Patient received aspirin within 24 hours prior to anesthesia start time (Peri2)
•9001F-Aortic aneurysm less than 5.0 cm maximum diameter on centerline formatted CT or minor diameter on axial formatted CT (NMA-No Measure Associated)
•9002F-Aortic aneurysm less than 5.0 – 5.4 cm maximum diameter on centerline formatted CT or minor diameter on axial formatted CT (NMA-No Measure Associated)
•9003F-Aortic aneurysm less than 5.5 – 5.9 cm maximum diameter on centerline formatted CT or minor diameter on axial formatted CT (NMA-No Measure Associated)
•9004F-Aortic aneurysm less than 6.0 cm or greater maximum diameter on centerline formatted CT or minor diameter on axial formatted CT (NMA-No Measure Associated)
•9005F-Asyptomatic carotid stenosis: No history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory (NMA – No Measure Associated)
•9006F-Symptomatic carotid stenosis: Ipsilateral carotid territory TIA or stroke less than 120 days prior to procedure (NMA-No Measure Associated)
•9006F-Other carotid stenosis: Ipsilateral TIA or stroke 120 days or greater prior to procedure or any prior contralateral carotid territory or vertebrobasilar TIA or stroke (NMA-No Measure Associated)
0078T -Endovascular repair using prosthesis of abdominal aortic aneurysm, pseudoaneurysm for dissection, abdominal aorta involving visceral branches, superior mesenteric, celiac and/or renal artery(s)
0078T -Endovascular repair using prosthesis of abdominal aortic aneurysm, pseudoaneurysm for dissection, abdominal aorta involving visceral branches, superior mesenteric, celiac and/or renal artery(s)
0079T -Placement of visceral extension prosthesis for endovascular repair of endovascular repair of abdominal aortic aneurysm involving visceral vessels, each visceral branch
0079T -Placement of visceral extension prosthesis for endovascular repair of endovascular repair of abdominal aortic aneurysm involving visceral vessels, each visceral branch
0080T -Endovascular repair using prosthetics of abdominal aorta aneurysm, pseudoaneurysm/dissection abdominal aorta involving visceral vessels, , superior mesenteric, celiac and/or renal artery(s), radiologic supervision and interpretation
0080T -Endovascular repair using prosthetics of abdominal aorta aneurysm, pseudoaneurysm/dissection abdominal aorta involving visceral vessels, , superior mesenteric, celiac and/or renal artery(s), radiologic supervision and interpretation
0081T -Placement o visceral extension prosthesis for endovascular repair of abdominal aortic aneurysm involving visceral vessels, each visceral branch, radiological supervision and interpretation
0081T -Placement o visceral extension prosthesis for endovascular repair of abdominal aortic aneurysm involving visceral vessels, each visceral branch, radiological supervision and interpretation
0124T -Conjunctival incision with posterior extrascleral placement of pharmacological agent (does not include supply of medication)
0124T -Conjunctival incision with posterior extrascleral placement of pharmacological agent (does not include supply of medication)
0183T -Low frequency, non-contact, non-thermal ultrasound, including topical allicatin(s), when performed wound assessment, and instruction(s) for ongoing care, per day
0183T -Low frequency, non-contact, non-thermal ultrasound, including topical allicatin(s), when performed wound assessment, and instruction(s) for ongoing care, per day
0185T -Multivariate analysis patient specific finding with quanfiable complex  problem assessment, including report
0185T- Multivariate analysis patient specific finding with quanfiable complex  problem assessment, including report
0186T – Suprachoroidal delivery of pharmacologic agent (does not include supply of medication)
0186T - Suprachoroidal delivery of pharnacologic agent (does not include supply of medication);
0192T – External approach
0192T - External approach
0260T -Total body system hypo, day, neonate less than <= 28 days
0260T -Total body system hypo, day, neonate less than <= 28 days
0261T –Selective head hypothermia, per day, in the neonate 28 days of age or younger
0261T-Selective head hypothermia, per day, in the neonate, 28 days of age or younger
0318T – Implantation of catheter delivered prosthetic aortic heart valve, open thoracic approach, (e.g., transapical, other than transaortic);
0318T Implantation of catheter-delivered prosthetic aortic heart valve, open thoracic approach, (e.g., transapical, other than transaortic); 
•0320T – Insertion of subcutaneous defibrillator electrode
•0321T  - Insertion of subcutaneous implantable defibrillator pulse generator only with existing subcutaneous electrode
•0322T – Removal of subcutaneous implantable defibrillator pulse generator only
•0323T – Removal of subcutaneous implantable defibrillator pulse generator with replacement of subcutaneous implantable defibrillator pulse generator only
•0324T – Removal of subcutaneous defibrillator electrode
•0325T – Repositioning of subcutaneous implantable defibrillator electrode and/or pulse generator
•0326T - Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters
•0327T – Interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable subcutaneous lead defibrillator system
•0328T – Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, implantable subcutaneous lead defibrillator system
•0329T - Monitoring of intraocular pressure for 24 hours or longer, unilateral or bilateral, with interpretation and report
•0330T – Tear film imaging, unilateral or bilateral, with interpretation and report
•0331T – Myocardial sympathetic innervation imaging, planar qualitative and quantitative assessment;
•0332T – with tomographic SPECT
•0333T – Visual evoked potential, screening of visual acuity, automated
•0334T – Sacroiliac joint stabilization for arthrodesis, percutaneous or minimally invasive (indirect visualization), includes obtaining and applying autograft or allograft (structural or morselized), when performed, includes image guidance when performed (eg, CT or fluoroscopic)
⦿0335T - Extra-osseous subtalar joint implant for talotarsal stabilization
•0336T - Laparoscopy, surgical, ablation of uterine (fibroid(s), including intraoperative ultrasound guidance and monitoring, radiofrequency
•0337T - Endothelial function assessment, using peripheral vascular response to reactive hyperemia, non-invasive (e.g., brachial artery ultrasound, peripheral artery tonometry), unilateral or bilateral
•0338T - Transcatheter renal sympathetic denervation, percutaneous approach including arterial puncture, selective catheter placement(s) renal artery(ies), fluoroscopy, contrast Injection (s), intraprocedural roadmapping and and radiological supervision and interpretation, including pressure gradient measurements, flush aortogram and diagnostic renal angiography when performed; unilateral
•0339T -     bilateral

No comments:

Post a Comment